Skip to main content
OpenTrials

Clinical trial condition

Pulmonary Disease, Chronic Obstructive

Explore clinical trials studying Pulmonary Disease, Chronic Obstructive. Study availability and eligibility vary by location and protocol.

787 public trials 11 recruiting studies
Refine in advanced search Browse all conditions

Pulmonary Disease, Chronic Obstructive trial results

Completed

A Study To Assess Efficacy And Safety Of Different Doses Of GW642444 In Subjects With Chronic Obstructive Pulmonary Disease (COPD)

NCT00606684

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • GSK Investigational Site Florence, Alabama, United States
  • GSK Investigational Site Jasper, Alabama, United States
  • GSK Investigational Site Montgomery, Alabama, United States
  • GSK Investigational Site Fullerton, California, United States
View all 99 locations
View Trial Details
Completed

Advair HFA For Chronic Obstructive Pulmonary Disease(COPD)

NCT00633217

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • GSK Investigational Site Jasper, Alabama, United States
  • GSK Investigational Site Mobile, Alabama, United States
  • GSK Investigational Site Lafayette, Louisiana, United States
  • GSK Investigational Site New Orleans, Louisiana, United States
View all 16 locations
View Trial Details
Completed

A 4-week Dose-Ranging, Dose-Interval, Efficacy, Safety and Tolerability Study of GSK961081 in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

NCT01319019

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • GSK Investigational Site Tallinn, Estonia
  • GSK Investigational Site Tallinn, Estonia
  • GSK Investigational Site Tallinn, Estonia
  • GSK Investigational Site Tartu, Estonia
View all 49 locations
View Trial Details
Completed

A Study to Assess the Safety and Tolerability of Once Daily Inhaled Doses of GSK573719 Made With Magnesium Stearate in Subjects With Chronic Obstructive Pulmonary Disease(COPD)for 7 Days

NCT00732472

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • GSK Investigational Site Reading, Berkshire, United Kingdom
  • GSK Investigational Site Buckshaw Village, Chorley, Lancashire, United Kingdom
  • GSK Investigational Site Waterloo, Liverpool, Merseyside, United Kingdom
  • GSK Investigational Site Clydebank, Glasgow, United Kingdom
View Trial Details
Completed

A 24-Week Study to Evaluate the Safety and Efficacy of ADVAIR DISKUS® Inhaler 250/50mcg Plus SPIRIVA HANDIHALER® Inhaler Versus SPIRIVA HANDIHALER® Inhaler Plus Placebo DISKUS® Inhaler in Subjects With Chronic Obstructive Pulmonary Disease (COPD).

NCT00784550

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • GSK Investigational Site Riverside, California, United States
  • GSK Investigational Site Fort Collins, Colorado, United States
  • GSK Investigational Site Clearwater, Florida, United States
  • GSK Investigational Site DeLand, Florida, United States
View all 35 locations
View Trial Details
Completed

Evaluating the Control of COPD Symptoms in Patients Treated With Tiotropium Bromide 18mcg Once Daily Alone, ADOAIR 50/250mcg Twice Daily Alone or ADOAIR 50/250mcg Plus Tiotropium Bromide 18mcg

NCT01762800

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • GSK Investigational Site Fukuoka, Japan
  • GSK Investigational Site Fukuoka, Japan
  • GSK Investigational Site Hiroshima, Japan
  • GSK Investigational Site Hiroshima, Japan
View all 39 locations
View Trial Details
Completed

Safety And Efficacy Of GSK233705 Plus Salmeterol Compared With 2 Active Comparators And Placebo In Subjects With Chronic Obstructive Pulmonary Disease (COPD)

NCT00422604

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • GSK Investigational Site Helsinki, Finland
  • GSK Investigational Site Wiesbaden, Hesse, Germany
  • GSK Investigational Site Großhansdorf, Schleswig-Holstein, Germany
  • GSK Investigational Site Almelo, Netherlands
View Trial Details

Related conditions